心肌梗死后低密度脂蛋白胆固醇降低幅度与他汀强度及主要不良结局的瑞典全国队列研究
该瑞典全国队列研究纳入40 607例心肌梗死患者,随访中位3.78年,分析心梗后至6-10周随访时LDL-C变化与他汀强度对预后的关联。结果显示LDL-C降低幅度越大、出院时使用高强度他汀且LDL-C降幅≥50%者,所有心血管结局及全因死亡风险均更低,支持心梗后早期强化降脂。
要点
- 心梗后LDL-C降低幅度越大,主要心血管事件和全因死亡风险越低
- 出院时使用高强度他汀且LDL-C降幅≥50%者所有结局发生率更低
- 结果支持心梗后早期强化他汀降脂以改善预后
核心结论
- 心梗后早期LDL-C降低幅度更大及出院时他汀强度更高,与所有心血管结局及全因死亡风险降低相关。
- 该真实世界数据支持临床试验提示的心梗后早期降低LDL-C获益最大。
研究设计与样本
- 瑞典全国队列研究,纳入40 607例心肌梗死患者。
- 分析心梗至6-10周随访时LDL-C变化,随访中位3.78年,采用校正Cox回归评估LDL-C变化四分位组及他汀强度与结局的关联。
主要发现
- LDL-C中位降低1.20 mmol/L。
- LDL-C降幅较大组(1.85 mmol/L,第75百分位)相比降幅较小组(0.36 mmol/L,第25百分位),复合终点(心血管死亡、心梗、缺血性卒中)HR 0.77(95%CI 0.70-0.84)。
- 全因死亡HR 0.71(95%CI 0.63-0.80),心血管死亡HR 0.68(95%CI 0.57-0.81)。
- 心肌梗死HR 0.81(95%CI 0.73-0.91),缺血性卒中HR 0.76(95%CI 0.62-0.93)。
- 心衰住院HR 0.73(95%CI 0.63-0.85),冠状动脉血运重建HR 0.86(95%CI 0.79-0.94)。
关键数值与推荐
- 出院时使用高强度他汀且LDL-C降幅≥50%的患者,相比使用较低强度他汀者,所有结局发生率更低。
临床怎么用
- 心梗后应尽早启动并维持高强度他汀,追求LDL-C大幅降低(如≥50%),以降低心血管事件和死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular (CV) events. This has, however, not yet been shown in a real-world setting. We aimed to investigate the association between LDL-C changes and statin intensity with prognosis after a myocardial infarction (MI). METHODS AND RESULTS: Patients admitted with MI were followed for mortality and major CV events. Changes in LDL-C between the MI and a 6- to 10-week follow-up visit were analysed. The associations between quartiles of LDL-C change and statin intensity with outcomes were assessed using adjusted Cox regression analyses. A total of 40 607 patients were followed for a median of 3.78 years. The median change in LDL-C was a 1.20 mmol/L reduction. Patients with larger LDL-C reduction (1.85 mmol/L, 75th percentile) compared with a smaller reduction (0.36 mmol/L, 25th percentile) had lower hazard ratios (HR) for all outcomes (95% confidence interval): composite of CV mortality, MI, and ischaemic stroke 0.77 (0.70-0.84); all-cause mortality 0.71 (0.63-0.80); CV mortality 0.68 (0.57-0.81); MI 0.81 (0.73-0.91); ischaemic stroke 0.76 (0.62-0.93); heart failure hospitalization 0.73 (0.63-0.85), and coronary artery revascularization 0.86 (0.79-0.94). Patients with ≥50% LDL-C reduction using high-intensity statins at discharge had a lower incidence of all outcomes compared with those using a lower intensity statin. CONCLUSIONS: Larger early LDL-C reduction and more intensive statin therapy after MI were associated with a reduced hazard of all CV outcomes and all-cause mortality. This supports clinical trial data suggesting that earlier lowering of LDL-C after an MI confers the greatest benefit.
引用
- Schubert J, Lindahl B, Melhus H, et al. Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. Eur Heart J. 2021. PMID: 33367526. doi:10.1093/eurheartj/ehaa1011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。